Immuron Limited (ASX:IMC)

Australia · Delayed Price · Currency is AUD

0.0280

0.00 (0.00%)

Mar 4, 2026, 2:54 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Hyperimmune Products	7.29M	4.90M	1.80M	765.19K	145.78K
Hyperimmune Products Growth	48.63%	171.67%	135.85%	424.91%	-94.21%
Total	7.29M	4.90M	1.80M	765.19K	145.78K
Total Growth	48.63%	171.67%	135.85%	424.91%	-94.21%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
United States (US)	1.66M	1.08M	642.82K	501.23K	4.26K
United States (US) Growth	54.18%	67.33%	28.25%	11654.88%	-99.54%
Canada	378.71K	80.89K	1.20K	63.17K	101.64K
Canada Growth	368.19%	6635.05%	-98.10%	-37.85%	-66.34%
Australia	5.25M	3.75M	1.16M	200.79K	39.87K
Australia Growth	40.13%	222.77%	478.05%	403.58%	-96.91%
Total	7.29M	4.90M	1.80M	765.19K	145.78K
Total Growth	48.63%	171.67%	135.85%	424.91%	-94.21%

Source: S&P Global Market Intelligence.